INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

20,303 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
22
SS
Sankar ShyamSee Remarks
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$4.55M
35.0K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

Page 198 of 508
← PrevNext →
22
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Open-market sale · 10b5-1 plan
SELL
$680K
24.7K sh
Jul 2, 2026
Jul 7, 2026
traded Jul 2, 2026
+5d
SEC Form 4

Evidence

22
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$4,424
1,036 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

22
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$129K
651 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

22
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
1,160 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

20
Josh GottheimerDJoint
NTDOYNintendo Co Ltd ADR
Partial sale
SELL$1,001 – $15KJun 17, 2026Jul 7, 2026
traded Jun 17, 2026
+20dHouse PTR

Evidence

20
Josh GottheimerDJoint
NSRGYNESTLE S.A S/ADR
Partial sale
SELL$1,001 – $15KJun 1, 2026Jul 7, 2026
traded Jun 1, 2026
+36dHouse PTR

Evidence

20
April McClain DelaneyDDependent child
CNMCore & Main, Inc.
Partial sale
SELL$1,001 – $15KJun 12, 2026Jul 7, 2026
traded Jun 12, 2026
+25dHouse PTR

Evidence

20
April McClain DelaneyDDependent child
LYVLive Nation Entertainment, Inc.
Partial sale
SELL$1,001 – $15KJun 2, 2026Jul 7, 2026
traded Jun 2, 2026
+35dHouse PTR

Evidence

20
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$1.29M
9,043 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

20
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$1.29M
9,043 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

19
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$750K
103.0K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
200 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$7,979
40 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$308K
1,540 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$362K
1,820 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
240 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

19
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$447K
10.3K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

17
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$656
24 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

17
PM
Pauls MatthewDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$2,572
94 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

17
PM
Pauls MatthewDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$18K
692 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

17
GP
Greenleaf PeterDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$19K
712 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

17
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$14K
534 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

17
XC
Xu Cong ClaireSVP, Clinical Development
NBPNovaBridge Biosciences
Open-market sale
SELL$3,992
4,485 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

17
UJ
Uczekaj JohnDirector, President and COO
AIROAIRO Group Holdings, Inc.
Open-market sale
SELL$1,195
154 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

17
GP
Greenleaf PeterDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$2,318
85 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

16
VA
Verma AbhimanyuChief Technology Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$27K
5,285 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
April McClain DelaneyDDependent child
WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
Partial sale
SELL$1,001 – $15KJun 12, 2026Jul 7, 2026
traded Jun 12, 2026
+25dHouse PTR

Evidence

16
CJ
Camblong JurgiDirector, Executive Chairman
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$118K
22.5K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$185
43 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$170K
840 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$177K
880 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$58K
280 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
320 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
MR
Muken RossDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$51K
9,838 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$217K
1,058 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$97K
480 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$130K
637 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$143K
720 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$1,445
333 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence